23: COVID-19 and Cardiovascular Disease
\u201cWe are at war with a pandemic and the enemy is not each other, it\u2019s the virus.\u201d \n\n \nIn this latest episode, Ankur Kalra, MD meets with Andrew Sauer, MD, co-author of upcoming paper in US Cardiology Review on COVID-19 and Cardiovascular Disease that provides a concise and current summary of cardiovascular complications from COVID-19. \n\n \n\nHear them discuss the latest issues surrounding the pandemic, the known cardiac implications and the rapidly emerging data. \n\n \n\nSubmit your question to Ankur via: podcast@radciffe-group.com. Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO. \n\n \n \n\nWhat to listen for: \n\n \n\nIn this episode they discuss: \n\n \n\n[00.00] Introductions \n\n[05.55] The importance of lessons learned from other countries and the importance of social distancing \n\n[09.25] Troponin elevation in COVID-19 positive patients \n\n[13.15] Receptor mechanisms and treating COVID-19 patients with hypertension \n\n[19.19] Cardiac arrhythmia mechanisms in COVID-19 patients \n\n[23.00] Fulminant myocarditis, congestive heart failure and BNP in COVID-19 patients \n\n[26.47] Treatments and risks: antiviral therapy, infection markers, complications \n\n[28.59] HCPs, PPE and the importance of social distancing \n\n[32.52] Antimalarial drugs in treating COVID-19 patients \n\n[34.54] Transplant patients, donors and testing for COVID-19 \n\n[39.35] The importance of surveillance biopsies \n\n[42.18] Pressure rooms for at-risk patients \n\n[45.05] Closing remarks